Pathogenesis and prevalence of hypertension in acromegaly.
about
Pasireotide: a novel treatment for patients with acromegalyChallenges in the diagnosis and management of acromegaly: a focus on comorbidities.Growth hormone and its disordersEtiologic aspects and management of acromegaly.A case and review of acromegaly-induced cardiomyopathy and the relationship between growth hormone and heart failure: cause or cure or neither or both?Multiple facets in the control of acromegaly.7th Brazilian Guideline of Arterial Hypertension: Chapter 12 - Secondary Arterial HypertensionAcromegaly: clinical features at diagnosis.Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management.Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.Cerebral aneurysm and acromegaly: a case report.Hypertensive emergency: A unique manifestation of a pituitary disorder.Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease.Left ventricular twist is impaired in acromegaly: Insights from the three-dimensional speckle tracking echocardiographic MAGYAR-Path Study.N-terminal pro-brain natriuretic peptide in newly diagnosed acromegaly.Assessment of cardiac autonomic functions by heart rate recovery, heart rate variability and QT dynamicity parameters in patients with acromegaly.Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study.Emerging trends in the diagnosis and treatment of acromegaly in Canada.Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system.Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice.Association between ACE and AGT polymorphism and cardiovascular risk in acromegalic patients.The growth hormone receptor polymorphism in patients with acromegaly: relationship to BMI and glucose metabolism.The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.Pattern of adrenal morphology and function in patients with acromegaly.
P2860
Q26774437-F344BF6D-D1DB-49F6-8D7F-374E7BE24563Q30249746-05588BDF-0A76-49D9-8432-8EC59DC02014Q36362200-EFCE18E1-7210-470B-B224-62B4D402D429Q36380875-C74C7F46-4E42-4385-AA0E-C6473A5CB14BQ36707004-4E1E35A4-FF66-4DFF-BE9B-4FA0F7559FF0Q37531066-FB4FC04D-BD08-48C0-9A69-70E0A03B518FQ37656171-E37CF3C7-9120-4C98-A705-076578980387Q38998304-2A5658E2-2E3A-4541-A312-77D8DADAA58FQ39064562-C6682A83-130B-4015-BAF7-F92F7B0738BAQ39146196-850500FE-A345-4520-BE5E-1C659698ED9AQ40456462-E3B16346-15D9-4A76-A465-BAACA6672601Q42095137-710B2375-3737-45F1-BEB1-DE03671B5D33Q42470520-C5A17908-30BF-4D86-B9C3-4E9BFE40B9B3Q42516541-0B724C38-B0FB-4914-B755-A1E1A526AB1DQ42866605-914578EE-5756-4BBF-86E1-729743289C8DQ43463519-EF290EAB-C01E-41B1-8B86-CD3A1C221C8CQ44466662-6933A4FD-20A8-4356-BEB6-8A91E758A72DQ44658146-3B5530B6-E032-4F3F-88A7-39CFEE3346F9Q44948397-EBD81668-C53B-42BD-9871-DFB0F80ADA1DQ45985284-33C68141-5D7A-4ED3-823C-20C3E2A4E019Q51260142-296E33ED-D787-44ED-80AC-9469C8CF6A77Q51370923-B8171DBE-97D4-4A11-8DAF-495821F08A38Q51374449-2609DBAF-29AD-4447-83B8-FA02C68A97D4Q53204823-5D486903-E942-4C5C-91A8-D61E609B80C8
P2860
Pathogenesis and prevalence of hypertension in acromegaly.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pathogenesis and prevalence of hypertension in acromegaly.
@ast
Pathogenesis and prevalence of hypertension in acromegaly.
@en
type
label
Pathogenesis and prevalence of hypertension in acromegaly.
@ast
Pathogenesis and prevalence of hypertension in acromegaly.
@en
prefLabel
Pathogenesis and prevalence of hypertension in acromegaly.
@ast
Pathogenesis and prevalence of hypertension in acromegaly.
@en
P2093
P356
P1433
P1476
Pathogenesis and prevalence of hypertension in acromegaly.
@en
P2093
Ambrosio MR
Bondanelli M
degli Uberti EC
P2888
P304
P356
10.1023/A:1020798430884
P577
2001-09-01T00:00:00Z
P6179
1035314904